Estrogenic activity of glycitein, a soy isoflavone.

Posted by Chantel. M studies contributed by  US National Library of Medicine National Institutes of Health

In the study to evaluate "Estrogenic activity of glycitein, a soy isoflavone" by Song TT, Hendrich S, Murphy PA., posted in US National Library of Medicine National Institutes of Health, researchers found that Weaning female B6D2F1 mice were dosed with glycitein (3 mg/day), genistein (3 mg/day), and diethylstilbestrol (DES) (0.03 microg/day) in 5% Tween 80 by gavage for 4 days. A control group received an equal volume of 5% Tween 80 solution daily. The uterine weight increased 150% with glycitein (p < 0.001), 50% with genistein (p < 0. 001), and 60% with DES (p < 0.001) compared with the control group. DES, 17beta-estradiol, and three isoflavones (daidzein, genistein, and glycitein) were examined for their competitive binding abilities with 17beta-((3)H)estradiol to the estrogen receptor proteins of the B6D2F1 mouse uterine cytosol. The concentrations of each compound required to displace 50% of the ((3)H)estradiol at 5 nM in the competitive binding assay were 1.15 nM DES, 1.09 nM 17beta-estradiol, 0.22 microM genistein, 4.00 microM daidzein, and 3.94 microM glycitein. These data indicated that glycitein has weak estrogenic activity, comparable to that of the other soy isoflavones but much lower than that of DES and 17beta-estradiol.


Dr. Mercola's Total Health Breakthrough
Guide To Weight Loss, Preventing Disease And
Premature Aging, And Living Healthy And Longer!


For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/